Fungal Infections Can Trigger And Exacerbate Asthma
Some academic research groups are using antifungal agents in asthma, with some success, Umetsu notes. In the future, he would like to target NKT cells in patients with severe asthma if a successful targeting method could be found.
The paper's first author was Lee Albacker, PhD, of the Division of Immunology at Boston Children's Hospital, who worked on the study as a graduate student in the Immunology Program at Harvard University. Coauthors were Vinod Chaudhary, PhD, and Paul Savage, PhD, of Brigham Young University, and Ya-Jen Chang, PhD, Hye Young Kim, PhD, Ya-Ting Chuang, PhD, Muriel Pichavant, PhD, Rosemarie DeKruyff, PhD, of Boston Children's Hospital.
The study was supported by the National Institute of Allergy and Infectious Diseases, the National Heart Lung Blood Institute (grants RO1AI026322, RC1HL099839 and R21AI083523) and by the Bunning Food Allergy Project.
Boston Children's Hospital is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 1,100 scientists, including seven members of the National Academy of Sciences, 13 members of the Institute of Medicine and 14 members of the Howard Hughes Medical Institute comprise Boston Children's research community. Founded as a 20-bed hospital for children, Boston Children's today is a 395 bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Boston Children's is also the primary pediatric teaching affiliate of Harvard Medical School. For more information about research and clinical innovation at Boston Children's, visit: http://vectorblog.org .CONTACT: Cyndi LeporeBoston Children's Hospital617-919-3110 Cynthia.Lepore@childrens.harvard.edu SOURCE Boston Children's Hospital
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV